2008
DOI: 10.1186/1479-5876-6-7
|View full text |Cite
|
Sign up to set email alerts
|

Human embryonic stem cells: preclinical perspectives

Abstract: Human embryonic stem cells (hESCs) have been extensively discussed in public and scientific communities for their potential in treating diseases and injuries. However, not much has been achieved in turning them into safe therapeutic agents. The hurdles in transforming hESCs to therapies start right with the way these cells are derived and maintained in the laboratory, and goes up-to clinical complications related to need for patient specific cell lines, gender specific aspects, age of the cells, and several po… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0
4

Year Published

2008
2008
2019
2019

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 35 publications
(23 citation statements)
references
References 81 publications
(72 reference statements)
0
19
0
4
Order By: Relevance
“…Such cells when injected into immunocompromised hosts are believed to form teratomas. At present, this property of ES cells is a major limitation to their clinical utility (23). We wondered whether in contrast to our observations regarding differentiation, a reciprocal relationship existed between membrane potential and teratoma formation.…”
Section: Resultsmentioning
confidence: 63%
“…Such cells when injected into immunocompromised hosts are believed to form teratomas. At present, this property of ES cells is a major limitation to their clinical utility (23). We wondered whether in contrast to our observations regarding differentiation, a reciprocal relationship existed between membrane potential and teratoma formation.…”
Section: Resultsmentioning
confidence: 63%
“…Nevertheless, ESCs present several problems for cell transplant therapy (Deb and Sarda, 2008;Daley and Scadden, 2008, for reviews). First is the possibility of contamination of the ESCs from mouse feeder layers or animal serum-supplemented medium with pathogens or xenogens (cells or proteins) that might trigger host immune reactions.…”
Section: Issues Surrounding the Use Of Ascs And Escs For Cellbased Thmentioning
confidence: 99%
“…Note-se que estes três genes, isolados ou em associação entre eles, são responsáveis pela expressão de mais de 2.000 outros genes envolvidos nos processos de autorrenovação e de manutenção da plasticidade e pluripotência das células-tronco. 66 O fenótipo de amniócitos mesenquimais humanos expandidos em cultura é similar ao relatado para células-tronco mesenquimais derivadas de tecido fetal do segundo trimestre de gestação e medula óssea de adulto. As AF-MSCs humanas podem diferenciar-se em uma ampla gama de células.…”
Section: Diferenciação Das Células-tronco Mesenquimais Do Líquido Amnunclassified